A Medicare-covered program that offers support and medical advice for caregivers of patients with dementia may bring more benefit than a costly Alzheimer's medication, research finds. UC San Francisco researchers have compared outcomes for patients in collaborative care programs with those taking lecanemab, one of two approved drugs that have been shown to slow progression of Alzheimer's in some patients.
Source: https://medicalxpress.com/news/2026-02- ... perts.html
-
Translation